Cytokinetics Inc (CYTK)
Gross profit margin
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross profit (ttm) | US$ in thousands | -164,504 | -92,465 | -90,470 | -170,640 | -243,952 | -312,350 | -290,415 | -176,246 | -146,225 | -61,062 | -43,842 | -109,284 | -89,510 | -124,111 | -63,626 | -48,223 | -41,123 | -31,746 | -63,406 | -62,089 |
| Revenue (ttm) | US$ in thousands | 18,474 | 3,219 | 3,134 | 3,752 | 7,530 | 7,815 | 9,952 | 98,053 | 94,588 | 148,231 | 151,153 | 65,028 | 70,428 | 21,550 | 57,801 | 58,551 | 55,828 | 54,318 | 18,685 | 22,229 |
| Gross profit margin | -890.46% | -2,872.48% | -2,886.73% | -4,547.97% | -3,239.73% | -3,996.80% | -2,918.16% | -179.75% | -154.59% | -41.19% | -29.01% | -168.06% | -127.09% | -575.92% | -110.08% | -82.36% | -73.66% | -58.44% | -339.34% | -279.32% |
December 31, 2024 calculation
Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $-164,504K ÷ $18,474K
= -890.46%
The gross profit margin of Cytokinetics Inc has shown significant fluctuations over the periods provided in the data. The margins have been consistently negative, indicating that the company's cost of goods sold has been exceeding its revenues from sales.
The gross profit margin ranged from -279.32% to -4,547.97% during the period. These extreme negative values suggest that the company has been incurring substantial losses on its production and sales activities.
Of note, there seem to be some errors in the data as gross profit margins exceeding -100% and extending into the thousands of percentage points are highly unusual and likely indicative of data inaccuracies or anomalies.
Overall, based on the trend of negative gross profit margins, it appears that Cytokinetics Inc has been facing challenges in effectively managing its production costs relative to its revenue generation. Further investigation into the underlying causes of these consistently negative margins would be warranted to address the financial performance of the company.
Peer comparison
Dec 31, 2024